Prof. Mehmet Nejat DALAY

Publication Network

Articles 67

1. No Tumor Suppressor Role for LKB1 in Prostate Cancer

Koseoglu H., Celebi A., Galamiyeva G., Dalay N., Ozkardes H., BUYRU A. N.

DNA AND CELL BIOLOGY , vol.40, pp.1222-1229, 2021 (SCI-Expanded) Sustainable Development

2. Epigenetic Silencing of SOX15 Is Controlled by miRNAs rather than Methylation in Papillary Thyroid Cancer

ÖZAYDIN A., Soysal A., Seyhan B., Arikan S., Dalay N., BUYRU A. N.

DISEASE MARKERS , vol.2021, 2021 (SCI-Expanded) Sustainable Development

3. Downregulation of Forkhead Transcription Factor (FOXO3a) Contributes to Tumorigenesis of Acute Myeloid Leukemia and Chronic Myeloid Leukemia

Odemis D. A., Yazici H., Gurbuz O., Tuncer S. B., Erdogan O. S., Erciyas S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.1, pp.28-35, 2021 (SCI-Expanded)

4. Analysis of gene copy number changes in head and neck cancer

Baltaci E., Karaman E., Dalay N., Buyru N.

CLINICAL OTOLARYNGOLOGY , vol.43, no.4, pp.1004-1009, 2018 (SCI-Expanded) Sustainable Development

5. Copy number alterations in lung cancer

Dalay N., Baykara O., Bakir B., Demirkaya A., Buyru N.

EUROPEAN JOURNAL OF CANCER , vol.50, 2014 (SCI-Expanded) Sustainable Development

6. Differential expression of long non coding RNAs during genotoxic stress induced apoptosis in HeLa and MCF 7 cells

ÖZGÜR E., MERT U., IŞIN M., OKUTAN M., DALAY N., GEZER U.

Clinical and experimental medicine , vol.13, no.2, pp.119-126, 2013 (SCI-Expanded) Sustainable Development

7. Temel Bilimler ve Laboratuvar : Moleküler Biyolog Bakışı

DALAY M. N.

TÜRKİYE KLİNİKLERİ MEDİKAL ONKOLOJİ DERGİSİ , vol.4, no.2, pp.1-6, 2011 (Peer-Reviewed Journal)

8. Testing the putative effect of Dicer-substrate siRNAs in regulating gene expression at transcriptional level

Kovancilar M., Dalay M. N., Deligezer U.

TURKISH JOURNAL OF BIOLOGY , vol.35, no.4, pp.399-404, 2011 (SCI-Expanded)

9. Assessment of microsatellite instability in head and neck cancer using consensus markers.

Yalniz Z., Demokan S., Suoglu Y., Ulusan M., Dalay N.

Molecular biology reports , vol.37, no.7, pp.3541-5, 2010 (SCI-Expanded) Sustainable Development

10. Detection of bone marrow micrometastases by reverse-transcriptase polymerase chain reaction (RT-PCR) in patients with early breast cancer Erken evre meme kanserinde revers transkriptaz polimeraz zincir reaksiyonu (RT-PCR) tekniǧi ile kemik iliǧi mikrometastazlarinin araştirilmasi

Cabioǧlu N., Yildirim E. O., Bitişik Ö., Yazici H., Müslümanoǧlu M., Dalay N., et al.

Turk Onkoloji Dergisi , vol.23, no.2, pp.55-62, 2008 (SCI-Expanded) Sustainable Development

11. Erken Evre Meme Kanserinde Revers Transkriptaz Polimeraz Zincir Reaksiyonu Tekniği ile Kemik İliği Mikrometastazlarının Araştırılması

CABİOĞLU N., YILDIRIM O., Bitişik Ö., YAZICI ÖZBEK H., MÜSLÜMANOĞLU M. E., DALAY M. N., et al.

TÜRK ONKOLOJİ DERGİSİ , vol.23, no.2, pp.55-62, 2008 (Scopus) Sustainable Development

12. Detection of bone marrow micrometastases by reverse-transcriptase polymerase chain reaction (RT-PCR) in patients with early breast cancer

Cabioalu N., Yildirim E. O., Bitisik O., YAZICI H., Muslumanoalu M., Dalay N., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.23, no.2, pp.55-62, 2008 (ESCI)

13. Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer

Demokan S., SÜOĞLU Y. H., Demir D., Gözeler M., Dalay N.

ANNALS OF ONCOLOGY , vol.17, no.6, pp.995-999, 2006 (SCI-Expanded) Sustainable Development

14. Matriks Metalloproteinazlar ve Akciğer Kanseri

OĞUZ H., Çamlıca H., DURANYILDIZ H. D., KAYTAN SAĞLAM E., TAŞ F., YASASEVER F. V., et al.

TÜRK ONKOLOJİ DERGİSİ , vol.21, no.2, pp.53-56, 2006 (Peer-Reviewed Journal) Sustainable Development

15. Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma

Deligezer U., Erten N., Akisik E. E., Dalay N.

EXPERIMENTAL AND MOLECULAR PATHOLOGY , vol.80, no.1, pp.72-76, 2006 (SCI-Expanded) Sustainable Development

16. Methylation of the INK4A/ARF locus in blood mononuclear cells

Deligezer U., Erten N., Akisik E. E., Dalay N.

ANNALS OF HEMATOLOGY , vol.85, no.2, pp.102-107, 2006 (SCI-Expanded)

17. Serum MMP-9 and TIMP-1 values in lung cancer

Hilal O. S., Yildiz D. D., Dalay N., Camlica H., Saglam K. E., Yasasever V.

TUMOR BIOLOGY , vol.27, pp.82, 2006 (SCI-Expanded) Sustainable Development

18. MTHFR C677T gene polymorphism in lymphoproliferative diseases

Deligezer U., Akisik E. E., Yaman F., Erten N., Dalay N.

JOURNAL OF CLINICAL LABORATORY ANALYSIS , vol.20, no.2, pp.37-41, 2006 (SCI-Expanded) Sustainable Development

19. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population

Deligezer U., Akisik E. E., Dalay N.

IN VIVO , vol.19, no.5, pp.889-893, 2005 (SCI-Expanded) Sustainable Development

20. p53 intronic G13964C variant in colon cancer and its association with HPV

Buyru N., Tezol A., Dalay N.

ANTICANCER RESEARCH , vol.25, no.4, pp.2767-2769, 2005 (SCI-Expanded) Sustainable Development

21. Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer

Demokan S., DEMIR D., süoğlu y., Kiyak E., AKAR U., DALAY N.

PATHOLOGY & ONCOLOGY RESEARCH , vol.11, no.1, pp.22-25, 2005 (SCI-Expanded) Sustainable Development

22. Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients

Deligezer U., Dalay N.

EXPERIMENTAL AND MOLECULAR MEDICINE , vol.36, no.6, pp.572-575, 2004 (SCI-Expanded) Sustainable Development

23. Is Free Beta Human Chorionic Gonadotropin A Useful Tumor Marker in Lung Cancer?

ORAL E. N., KİZİR A., DURANYILDIZ D., Çamlıca H., DEMOKAN S., YASASEVER V., et al.

JOURNAL OF TUMOR MARKER ONCOLOGY , vol.19, no.5, pp.337-340, 2004 (Peer-Reviewed Journal) Sustainable Development

24. Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk

Akisik E., Dalay N.

EXPERIMENTAL AND MOLECULAR PATHOLOGY , vol.76, no.3, pp.260-263, 2004 (SCI-Expanded) Sustainable Development

25. Lack of Expresion of Epstein-Barr and Human Papillomavirus Gene Products in Breast Cancer

IŞIN M., DALAY M. N.

JOURNAL OF TUMOR MARKER ONCOLOGY , vol.19, no.5, pp.331-335, 2004 (Peer-Reviewed Journal) Sustainable Development

26. Is Free Beta-HCG A Useful Tumor Marker in Lung Cancer

Oral E. N., KİZİR A., DURANYILDIZ H. D., Çamlıca H., DEMOKAN İSHAKOĞLU S., DALAY M. N.

JOURNAL OF TUMOR MARKER ONCOLOGY , vol.19, no.5, pp.337-340, 2004 (Peer-Reviewed Journal) Sustainable Development

27. Protein 90K, ICAM1, P-Selectin and Neopterin Levels in Turkish Breast Cancer Patients

YASASEVER F. V., DURANYILDIZ H. D., DİNÇER M., Çamlıca H., DEMOKAN İSHAKOĞLU S., DALAY M. N.

JOURNAL OF TUMOR MARKER ONCOLOGY , vol.19, no.3, pp.199-205, 2004 (Peer-Reviewed Journal) Sustainable Development

28. Kolon ve Rektum Tümörlerinin Moleküler Biyolojisi

AKIŞIK E., DALAY M. N.

KLİNİK LABORATUAR , vol.3, pp.1-9, 2004 (Peer-Reviewed Journal)

29. Vitamin D receptor gene polymorphisms in breast cancer

Buyru N., Tezol A., Yosunkaya-Fenerci E., Dalay N.

EXPERIMENTAL AND MOLECULAR MEDICINE , vol.35, no.6, pp.550-555, 2003 (SCI-Expanded) Sustainable Development

30. Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients

Deligezer U., Yaman F., Erten N., Dalay N.

CLINICA CHIMICA ACTA , vol.335, pp.89-94, 2003 (SCI-Expanded) Sustainable Development

31. Ras oncogene mutations in urine sediments of patients with bladder cancer

Buyru N., Tigli H., Ozcan E., Dalay N.

JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY , vol.36, no.4, pp.399-402, 2003 (SCI-Expanded) Sustainable Development

32. P53 codon 72 polymorphism in breast cancer

Buyru N., Tigli H., Dalay N.

ONCOLOGY REPORTS , vol.10, no.3, pp.711-714, 2003 (SCI-Expanded) Sustainable Development

33. DNA Metilasyonu, İmprinting ve Kanser

YAZICI ÖZBEK H., DALAY M. N.

KLİNİK LABORATUAR , vol.2, no.2, pp.5-14, 2003 (Peer-Reviewed Journal) Sustainable Development

34. Detection of circulating melanoma cells by a two-marker polymerase chain reaction assay in relation to therapy.

Bitisik O., Camlica H., Duranyildiz D., Tas F., Kurul S., Dalay N.

Journal of biochemistry and molecular biology , vol.36, no.2, pp.173-8, 2003 (SCI-Expanded, Scopus) Sustainable Development

35. Serum CD44, sICAM, 90K Protein and Neopterin Levels in Lung Cancer

DALAY M. N., KİZİR A., YASASEVER F. V., DEMOKAN İSHAKOĞLU S.

JOURNAL OF TUMOR MARKER ONCOLOGY , vol.17, no.4, pp.189-194, 2002 (Peer-Reviewed Journal) Sustainable Development

36. Age Adjusted PSA and Serum Prostate-Specific Antigem Levels in the Turkish Population

Çamlıca H., DURANYILDIZ H. D., YASASEVER F. V., DALAY M. N.

JOURNAL OF TUMOR MARKER ONCOLOGY , vol.17, no.3, pp.147-152, 2002 (Peer-Reviewed Journal)

37. Mitokondrial Kalıtım ve Kanser

YAZICI ÖZBEK H., DALAY M. N.

KLİNİK LABORATUAR , vol.1, no.2, pp.15-24, 2002 (Peer-Reviewed Journal) Sustainable Development

38. BRCA1 ve BRCA2 Genlerinin Bugün için Bilinen Fonksiyonları

YAZICI ÖZBEK H., DALAY M. N.

KLİNİK LABORATUAR , vol.1, no.1, pp.26-33, 2002 (Peer-Reviewed Journal)

39. Prognostic significance of melanoma inhibiting activity levels in malignant melanoma.

Meral R., Duranyildiz D., Tas F., Camlica H., Yasasever V., Kurul S., et al.

Melanoma research , vol.11, no.6, pp.627-32, 2001 (SCI-Expanded, Scopus)

40. Serum Total Antioxidant Levels are Loe in Cancer Patients

YASASEVER F. V., DURANYILDIZ H. D., DİNÇER M., Çamlıca H., Oral E. N., CENGİZ M., et al.

RESEARCH COMMUNICATIONS IN BIOCHEMISTRY AND CELLULAR AND MOLECULAR BIOLOGY , vol.4, pp.277-284, 2001 (Peer-Reviewed Journal) Sustainable Development

41. New urinary antigens as markers in bladder cancer

Yasasever V., Ozcan F., Camlica H., Nane I., Dalay N.

JOURNAL OF TUMOR MARKER ONCOLOGY , vol.16, no.2, pp.147-152, 2001 (SCI-Expanded) Sustainable Development

42. Serum c-erb B2 oncoprotein levels are elevated in recurrent and metastatic breast cancer

Yasasever V., Dincer M., Camlica H., Duranyildiz D., Dalay N.

CLINICAL BIOCHEMISTRY , vol.33, no.4, pp.315-317, 2000 (SCI-Expanded) Sustainable Development

43. Telomerase activity in patients with chronic myeloid leukemia and lymphoma

Bitisik O., Yavuz S., Yasasever V., Dalay N.

RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY , vol.107, pp.3-12, 2000 (SCI-Expanded)

44. Serum NSE levels in the Turkish population

Yasasever V., Meral R., Camlica H., Duranyildiz D., Dalay N.

JOURNAL OF TUMOR MARKER ONCOLOGY , vol.14, no.3, pp.35-40, 1999 (SCI-Expanded) Sustainable Development

45. CA242 and total antioxidant levels in comparison to CEA and CA 19-9 in colorectal cancer

Yasasever V., Oral E., Camlica H., Dalay N.

JOURNAL OF TUMOR MARKER ONCOLOGY , vol.14, no.1, pp.27-32, 1999 (SCI-Expanded) Sustainable Development

46. Diagnostic value of the PSA subfractions, acid phosphatase and creatine kinase isoenzymes in prostate cancer

Duranyildiz D., Camlica H., Yasasever V., Ozcan F., Dalay N.

JOURNAL OF TUMOR MARKER ONCOLOGY , vol.14, no.1, pp.39-46, 1999 (SCI-Expanded) Sustainable Development

47. Nazofarenks Kanserlerinde c-erbB2 Gen Amplifikasyonunun ve Onkoproein Düzeyinin Araştırılması

ALTUN M., YAZICI ÖZBEK H., HAFIZ G., DALAY M. N.

TÜRK OTOLARENGOLOJİ DERGİSİ , vol.36, pp.85-90, 1998 (Peer-Reviewed Journal) Sustainable Development

48. Serum c-erb B2 levels and breast cancer

Dalay N., Yasasever V., Camlica H., Karaloglu D., Dincer M.

FASEB JOURNAL , vol.11, no.3, pp.2455, 1997 (SCI-Expanded) Sustainable Development

49. Evaluation of phosphohexose isomerase as a metastasis marker in breast cancer patients

Yasasever V., Dincer M., Camlica H., Duranyildiz D., Dalay N.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.18, no.5, pp.397-399, 1997 (SCI-Expanded) Sustainable Development

50. Serum levels of mutant p53 protein in cancer

Karaloglu D., Yasasever V., Kizir A., Dalay N.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.15, no.4, pp.335-339, 1996 (SCI-Expanded) Sustainable Development

51. Serum c-erbB-2/neu: Is a common tumor marker?

Yasasever V., Dincer M., Karaloglu D., Camlica H., Dalay N.

IMMUNOLOGY , vol.89, 1996 (SCI-Expanded)

52. Evaluation of serum tumor markers in gastrointestinal tract tumors

Yasasever V., Karaloglu D., Kizir A., Camlica H., Dalay N.

JOURNAL OF TUMOR MARKER ONCOLOGY , vol.11, no.3, pp.29-33, 1996 (SCI-Expanded) Sustainable Development

53. Retinoblastomlu Çocuklarda XbaI RFLP Analizi ile Tümör Dokusunda Allel Kaybının Belirlenmesi

YAZICI ÖZBEK H., KIR N., TAŞ Ş., AYAN İ., KEBUDİ R., PEKSAYAR G., et al.

MEDİKAL BİYOTEKNOLOJİ VE MOLEKÜLER TIP , vol.1, no.2, pp.72-76, 1996 (Peer-Reviewed Journal)

54. ACUTE COAGULATION CHANGES DURING CYTOTOXIC CHEMOTHERAPY

ONAT H., INANC S., KARALOGLU D., ERTURK N., DALAY N., YASASEVER V.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.13, no.1, pp.89-92, 1994 (SCI-Expanded) Sustainable Development

55. The Effects of Selenium Supplementation on Wound Healing and Antioxidant Enzyme Activities

DELİLBAŞI E., DELILBAŞI L., TURAN B., DALAY M. N.

TURKISH JOURNAL OF MEDICAL RESEARCH , vol.11, no.2, pp.54-58, 1993 (Peer-Reviewed Journal)

56. The Effect of In Vıvo Selenium Supplementation on the Amplitude of the Spontaneous Contractions and Responses to Acetylcholine in Isolated Rabbit Ileum

DALAY M. N., TURAN B., AFRASYAP L., DELİLBAŞI E.

NEUROBIOLOGY , vol.1, no.1, pp.83-90, 1993 (Peer-Reviewed Journal)

57. EFFECT OF CISPLATIN ON ERYTHROPOIETIN AND IRON CHANGES

ONAT H., INANC S., DALAY N., KARALOGLU D., ERTURK N., YASASEVER V.

EUROPEAN JOURNAL OF CANCER , no.5, pp.777, 1993 (SCI-Expanded)

58. Serum neu Oncoproein Levels in Breast Cancer

YASASEVER F. V., DURANYILDIZ H. D., YAZICI ÖZBEK H., ONAT H., DALAY M. N.

JOURNAL OF TUMOR MARKER ONCOLOGY , vol.7, no.2, pp.33-43, 1992 (Peer-Reviewed Journal) Sustainable Development

59. SERUM SELENIUM AND GLUTATHIONE-PEROXIDASE ACTIVITIES AND THEIR INTERACTION WITH TOXIC METALS IN DIALYSIS AND RENAL-TRANSPLANTATION PATIENTS

TURAN B., DELILBASI E., DALAY N., SERT S., AFRASYAP L., SAYAL A.

BIOLOGICAL TRACE ELEMENT RESEARCH , vol.33, pp.95-102, 1992 (SCI-Expanded)

60. Therapeutic Selenium Supplementation Activities of Gluthathione Peroxidase and Superoxide Dismutase in Rabbit Tissues

TURAN B., DELİLBAŞI E., DALAY M. N., AFRASYAP L., ŞENGÜN Z.

ROMANIAN JOURNAL OF ADVANCES IN BIOPHYSICS , vol.2, no.2, pp.121-127, 1992 (Peer-Reviewed Journal)

61. THE EFFECT OF SELENIUM SUPPLEMENTATION ON THE NMR PROTON RELAXATION-TIME T1 IN PLASMA

TURAN B., YILMAZ A., DALAY N.

SPECTROSCOPY LETTERS , vol.25, no.8, pp.1405-1410, 1992 (SCI-Expanded)

62. Determination of Circulating Serum Free DNA and Magnesium Levels in Cancer Patients

DALAY M. N., TURAN B., SAYDAN N., ŞENGÜN Z., ÖZCAN T., DİNÇOL D., et al.

ANKARA ÜNİVERSİTESİ TIP FAKÜLTESİ DERGİSİ , vol.12, no.4, pp.331-337, 1991 (Peer-Reviewed Journal) Sustainable Development

63. Distribution of Selenium and Gluthathione Peroxidase in Rabbits Given Selenite

TURAN B., DELİLBAŞI E., IŞIMER A., DALAY M. N.

TURKISH JOURNAL OF MEDICAL RESEARCH , vol.10, no.2, pp.71-75, 1991 (Peer-Reviewed Journal)

64. A POSSIBLE RELATIONSHIP BETWEEN SERUM SATELLITE DNA AND CELLULAR ANTIOXIDATIVE MECHANISM

TURAN B., DALAY N., DELIBASI E.

SPECTROSCOPY LETTERS , vol.24, no.6, pp.865-871, 1991 (SCI-Expanded) Sustainable Development

65. BINDING OF PROTEIN UH2A AND HISTONE H2A TO DNA

KIRDAR B., DALAY N., BERMEK E.

CELL BIOPHYSICS , vol.14, no.1, pp.43-51, 1989 (SCI-Expanded)

66. ISOLATION OF PROTEIN-UH2A USING A ONE-STEP PREPARATIVE GEL-ELECTROPHORESIS

DALAY N., OZKAYNAK E., KIRDAR B., CARIN M., BERMEK E.

PREPARATIVE BIOCHEMISTRY , vol.14, no.2, pp.181-192, 1984 (SCI-Expanded)

67. Sıçan Karaciğer Kromatininin Kesimlendirilmesi ve Altkesimlerin Özellikleri

KIRDAR B., DALAY M. N., BERMEK E.

DOĞA BİLİM DERGİSİ , vol.3, pp.270-278, 1983 (Peer-Reviewed Journal)

Papers Presented at Peer-Reviewed Scientific Conferences 73

1. Expression of SOX15 and Wnt pathway genes in papillary thyroid carcinoma

Buyru A. N., Soysal A., Ozaydin A., Seyhan B., Arikan S., Dalay N.

Annual Meeting of the American-Association-for-Cancer-Research (AACR), Louisiana, United States Of America, 8 - 13 April 2022, (Summary Text)

2. Meme Kanserli Hastalarda WRN ve DSP Genlerinin Araştırılması

Işın H., IŞIN M., Talu C. K., Trabulus D., Karaçetin D., DALAY M. N.

XV. Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 26 - 29 October 2017, pp.118, (Full Text)

3. Amplification and overexpression of EMSY gene in NSCLC

BUYRU A. N., BAYKARA O., Bulut P., DALAY M. N.

Breakthroughs in Cancer Research: From Biology to Therapeutics., 16 - 20 February 2016, pp.32, (Full Text)

4. Meme Kanserli Hastalarda WRN ve DSP Genlerinde Genİfadesi ve Metillenme Değişikliklerinin Araştırılması

Işın H., IŞIN M., Talu C. K., Trabulus D., Karaçetin D., Aksoy Ş., et al.

XIV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2015, pp.121-122, (Summary Text)

5. DOK1 gene may act as a tumor suppressor in breast cancer

BUYRU A. N., Tuna E., ÖZDEMİR F., Bulut P., DALAY M. N.

Advances in breast cancer research, Bellevue, United States Of America, 17 - 20 October 2015, vol.14, no.2, pp.61, (Full Text) Sustainable Development

6. Increased DNA Integrity of Free Serum DNA in Patients with Colorectal Cancer

YÖRÜKER E. E., ÖZGÜR E., KESKİN M., DALAY M. N., GEZER U.

The 42nd Congress of the International Society of Oncology and Biomarkers, Zakopane, Poland, 3 - 07 October 2015, pp.50-51, (Full Text) Sustainable Development

7. Involvement of miRNA-29b in Breast Cancer

IŞIN M., Işın H., Talu C. K., Trabulus D., Karaçetin D., DALAY M. N.

microRNAs and non-coding RNAs in Cancer, Keystone, Colorado, United States Of America, 7 - 12 June 2015, (Full Text)

8. LKB1 loss is associated with Akt1 phosphorylation in head and neck cancer.

DALAY M. N., EKİZOĞLU ERATAK S., DOĞAN S., KARAMAN E., ÜLKER D., BUYRU A. N.

An AACR (American Association for Cancer Research) Special Conference on “TARGETING THE PI3K-mTOR NETWORK IN CANCER”, Philadelphia, United States Of America, 14 - 17 September 2014, (Full Text) Sustainable Development

9. Copy number alterations in lung cancer

DALAY M. N., BAYKARA O., Bakır B., Demirkaya A., BUYRU A. N.

23rd Biennial Congress of the European Association for Cancer Research, From Basic Research to Personalised Cancer Treatment Congress,, Münih, Germany, 5 - 08 July 2014, pp.93, (Full Text) Sustainable Development

10. Circulating MicroRNA expression analysis in papillary thyroid carcinoma

YÖRÜKER E. E., Terzioğlu D., TEKSÖZ S., USLU F. E., GEZER U., DALAY M. N.

41 Congress of the International Society of Oncology and Biomarkers, Barselona, Spain, 15 - 18 March 2014, pp.27-28, (Full Text)

11. **Kolorektal Kanser Hastalarında UGT1A1*28 Gen Polimorfizmi ve İrinotekan Toksisitesinin Araştırılması**

YÖRÜKER E. E., ŞEN F., Keskin S., AYKAN N. F., DALAY M. N.

XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Aydın, Turkey, 29 October - 01 November 2013, pp.196-197, (Full Text) Sustainable Development

12. Analysis of MRGBP and PPIL1 genes in colon cancer

YÖRÜKER E. E., DALAY M. N., Yamaner S., Buğra D.

Frontiers ib Basic Cancer Research, Maryland, United States Of America, 18 - 22 September 2013, pp.21, (Full Text) Sustainable Development

13. Circulating Long-none coding RNA (HOTAIR, GAS5, and LyncRNA p-21) levels in patients with nasopharyngeal cancer vs. other inoperable head and neck squamous cell cancer

IŞIN M., FAYDA E. M., Güveli M., TAMBAŞ M., GEZER U., MERAL R., et al.

6th International Congress on Nasopharyngeal carcinoma, Turkey, pp.0-38, (Full Text) Sustainable Development

14. Malign Melanomlu Hastalara Ait Primer Tümör Dokusundaki Metilasyon Değişikliklerinin 2 ve 3 Boyutlu Doku Kültür Ortamında Araştırılması

ŞÜKRÜOĞLU ERDOĞAN Ö., BİLİR A., KURUL S., DALAY M. N., YAZICI H.

20. Ulusal Kanser Kongresi, Antalya, Turkey, 19 April - 23 March 2013, pp.394, (Full Text)

15. 2008-2012 Yılları Arasında Kanser Genetiği Polikliniğine Başvuran Yüksek Riskli Meme/Over Kanser Sendromlu Vakalarının Dağılımı

AKDENİZ ÖDEMİŞ D., TUNÇER Ş. B., altundağ k., şükrüoğlu Ö., kılıç S., kılıç l., et al.

20. ULUSAL KANSER KONGRESİ, Antalya, Turkey, 19 - 23 April 2013, (Full Text) Sustainable Development

16. Akut Miyeloid Lösemi (AML) ve Kronik Miyeloid Lösemi (KML) Hastalarında FOXO3A Gen İfadesinin Araştırılması

AKDENİZ ÖDEMİŞ D., DALAY M. N.

20. ULUSAL KANSER KONGRESİ, Antalya, Turkey, 19 - 23 April 2013, (Full Text)

17. LKB1 downregulation in head and neck cancer is independent of promoter methylation or FOXO3 expression

DALAY M. N., Ekizoglu S., KARAMAN E., AKDENİZ ÖDEMİŞ D., ÖZAYDIN A., Buyru N.

AACR 104th Annual Meeting, Washington, United States Of America, 6 - 10 April 2013, (Full Text) Sustainable Development

18. Analysis of gene copy number changes in chronic lymphocytic leukemia

DALAY M. N., IŞIN M., Cetin G., AKTAN M.

Chromatin and Epigenetics in Cancer, Washington Dc, United States Of America, 6 - 10 April 2013, vol.73, no.13, (Full Text)

19. LKB1 Downregulation is Independent of Promoter Methylation or FOXO3 Expression in Head and Neck Cancer

DALAY M. N., EKİZOĞLU ERATAK S., KARAMAN E., AKDENİZ ÖDEMİŞ D., ÖZAYDIN A., BUYRU A. N.

American Association for Cancer Research 2013 (AACR 2013), Washington Dc, United States Of America, 6 - 10 April 2013, (Full Text) Sustainable Development

20. LKB1 Gene Mutations and Rheb Gene Expression in Renal Cell

Dalay N., Buyru N., Yalniz Z., Tigli H.

22nd Biennial Congress of the European-Association-for-Cancer-Research, Barcelona, Spain, 7 - 10 July 2012, vol.48, (Summary Text)

21. Investigation of lncRNAs in chronic lymphocytic leukemia and prostate cancer

IŞIN M., Özgür E., AKTAN M., GEZER U., DALAY M. N.

7th NCRI Cancer Conference, United Kingdom, 1 - 04 November 2011, pp.49, (Full Text) Sustainable Development

22. Characterization of H3K9me3- and H4K20me3-associated nucleosomal DNA by high-throughput sequencing in colorectal cancer

GEZER U., ÜSTEK D., AKIŞIK E. E., ÇAKİRİS A., ABACI N., Holdenrieder S., et al.

7th International Conference on Circulating Nucleic Acids in Plasma and Serum, Spain, 1 - 04 October 2011, pp.19, (Full Text) Sustainable Development

23. Kan plazmasında H3K9me3 ve H4K20me3 ilintili nükleozomal DNA’nın yeni nesil dizileme yöntemiyle karakterizasyonu

Mert U., ÜSTEK D., Özgür E., IŞIN M., DALAY M. N., GEZER U.

XII. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 1 - 04 October 2011, (Summary Text)

24. Investigation of plasma lncRNA levels in chronic lymphocytic leukemia and multiple myeloma patients

IŞIN M., Özgür E., AKTAN M., ERTEN S. N., GEZER U., DALAY M. N.

7th International Conference on Circulating Nucleic Acids in Plasma and Serum, Spain, 1 - 04 October 2011, pp.19, (Full Text)

25. Genotoksik stres ilintili apoptozda kodlanmayan RNA analizi

Özgür E., Mert U., IŞIN M., DALAY M. N., GEZER U.

XII. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 1 - 04 October 2011, (Summary Text)

26. The predictive role of midtreatment changes in survivin, GSTP1 and Topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

Keskin S., Eralp Y., Yılmaz E. Z., YÖRÜKER E. E., İĞCİ A., MÜSLÜMANOĞLU M. E., et al.

2011 ASCO Annual Meeting, United States Of America, 1 - 04 June 2011, pp.10539, (Full Text) Sustainable Development

27. Kaposi Sarkomlu Hastalarda E-Cadherin Gen Mutasyonlarının Araştırılması

TUNÇER Ş. B., ŞEN F., kılıç S., KURUL S., AYDINER A., YAZICI H., et al.

19.Ulusal Kanser Kongresi, Antalya, Turkey, 21 - 24 April 2011, pp.502, (Full Text)

28. Meme Kanserli Hastalara Ait PrimerTümör Dokusundaki Metilasyon Değişikliklerinin 2 ve 3 Boyutlu Doku Kültür Ortamında Araştırılması

ŞÜKRÜOĞLU ERDOĞAN Ö., YAZICI H., DALAY M. N., BİLİR A., KURUL S., KARANLIK H.

19. Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.485, (Full Text) Sustainable Development

29. Kronik Lenfositik Lösemili Hastalarda P53 Geni Ekzon 6 Değişikliklerinin İncelenmesi

IŞIN M., AKTAN M., BUYRU A. N., DALAY M. N.

XIX. Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.482, (Full Text)

30. Genotoksik stres varlığında genomda global DNA metillenme düzeyinin incelenmesi

GEZER U., Özgür E., DALAY M. N.

IX. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2011, pp.351, (Summary Text)

31. Kan dolaşımında histon modifikasyonlarının nükleozomlarla korelasyonu

GEZER U., Mert U., AKIŞIK E. E., DALAY M. N.

IX. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2011, (Full Text)

32. Prostat kanserli hastaların kan plazmalarında mikroRNA genlerinin incelenmesi

GEZER U., Kovancılar M., AĞAOĞLU F., DİZDAR M. Y., DARENDELİLER M. E., DALAY M. N.

IX. Ulusal Kanser Kongresi,, Antalya, Turkey, 1 - 04 April 2011, (Full Text) Sustainable Development

33. Kronik lenfositik lösemili hastaların plazmalarında serbest kodlamayan RNA’ların araştırılması

IŞIN M., Özgür E., AKTAN M., GEZER U., DALAY M. N.

IX. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2011, pp.376, (Full Text)

34. Investigation of miR-21, miR-141 and miR-221 in plasma of patients with prostate cancer

Kovancılar M., AĞAOĞLU F., DİZDAR M. Y., DARENDELİLER M. E., DALAY M. N., GEZER U.

IX Ulusal Tıbbi Genetik Kongresi, İstanbul, Turkey, 1 - 04 December 2010, pp.20, (Full Text) Sustainable Development

35. Using SELDI-TOF MS to Identify Serum Biomarkers in NSCLC.

BAYKARA O., BUYRU A. N., ULUTİN A. N. T., DALAY M. N.

4th AACR International Conference . Molecular Diagnostics in Cancer Therapeutic Development. Challenges and New Horizons, Denver, United States Of America, 27 - 30 September 2010, vol.16, no.19, pp.23, (Full Text)

36. Histon modifications in circulating nucleosomes as potential biomarker in cancer

GEZER U., YÖRÜKER E. E., Yılmaz E. Z., Kovancılar M., Buğra D., Holdenrieder S., et al.

38th Meeting of the International Society of Oncology and Biomarkers (ISOBM), Germany, 1 - 04 September 2010, pp.34, (Full Text) Sustainable Development

37. ZBTB7A AND BCL6 GENES ARE NOT EXPRESSED IN CLL

Isin M., Yenerel M. N., Aktan M., Buyru N., Dalay N.

38th Meeting of the International-Society-of-Oncology-and-BioMarkers (ISOBM), Munchen, Germany, 3 - 08 September 2010, vol.31, (Summary Text)

38. Methylation of the mismatch repair genes in head and neck cancer

Yalniz Z., Demokan S., Suoglu Y., Yilmazer R., Dalay N.

21st Meeting of the European-Association-for-Cancer-Research, Oslo, Norway, 26 - 29 June 2010, vol.8, pp.150-151, (Summary Text)

39. DNA Promoter Methylation in Breast Tumors Is Not Associated with Polymorphism in the GSTP1 Gene.

Dalay N., Tomekce B., Ozdemir F., Demokan S., Buyru N.

32nd Annual San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 9 - 13 December 2009, vol.69, (Summary Text)

40. Promoter Methylation in Breast Tumors Is Not Associated with Polymorphism in the GSTP1 Gene.

DALAY N., Tömekçe B., Ozdemir F., DEMOKAN S., Buyru N.

32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, United States Of America, 1 - 04 December 2009, vol.69 (24), no.3, pp.586, (Full Text)

41. H3K9me3/H4K20me3 ratio on circulating nucleosomes as potential biomarker for colorectal cancer

GEZER U., Akışık E. Z., AKIŞIK E. E., Kovancılar M., Buğra D., ERTEN S. N., et al.

6th International Conference on Circulating Nucleic Acids in Plasma and Serum, Hong Kong, 1 - 04 November 2009, (Full Text) Sustainable Development

42. Kolon-Rektum kanserli hastalarda GSTM-GSTT Gen Polimorfizmlerinin İncelenmesi

BAYKARA O., DALAY M. N., BUYRU A. N.

XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 21 - 26 April 2009, pp.93, (Full Text) Sustainable Development

43. Baş-boyun kanserinde proteomik serum biyomarker analizi

BAYKARA O., DALAY M. N., DEMOKAN S., BUYRU A. N.

XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 21 - 26 April 2009, pp.95, (Full Text) Sustainable Development

44. Kanserli hastaların periferik dolaşımlarında potansiyel biyomarker olarak histon modifikasyonları

GEZER U., Akışık E. Z., AKIŞIK E. E., Kovancılar M., Buğra D., ERTEN S. N., et al.

XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2009, pp.26, (Summary Text) Sustainable Development

45. Kolorektal kanserli hastalarda p16 tümör süpressor genindeki promotör metilasyonu ve H3lys9 metilasyonunun araştırılması.

AKIŞIK E. E., Akışık E. Z., GEZER U., Buğra D., YAMANER Y. S., DALAY M. N.

XVIII. ULusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2009, pp.26, (Full Text) Sustainable Development

46. siRNAs targeted to the CpG island region of the CDKN2A gene cause transcriptional gene silencing

GEZER U., Kovancılar M., DALAY M. N.

2009 AACR Annual Meeting, United States Of America, 1 - 04 April 2009, (Full Text)

47. Tümör baskılayıcı genlerin CpG adacıklarına hedeflendirilmiş siRNA’LAR transkripsiyonel gen baskılanmasına yol açmaktadır

GEZER U., Kovancılar M., DALAY M. N.

XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2009, pp.26, (Full Text)

48. Serum biomarkers for head and neck cancer by proteomic analysis

DALAY M. N., BAYKARA O., DEMOKAN S., BUYRU A. N.

Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine, Philadelphia, United States Of America, 22 - 25 September 2008, vol.14, no.19, pp.42, (Full Text) Sustainable Development

49. Methylation of the DAPK, HIN-1 and FHIT genes in head and neck cancer

Dalay N., Yalniz Z., Demokan S., Demir D., Gozeler M., Suoglu Y.

20th Meeting of the European-Association-for-Cancer-Research, Lyon, France, 5 - 08 July 2008, vol.6, pp.150, (Summary Text)

50. Detection of histone methylation on circulating nucleosomes in blood plasma.

GEZER U., AKIŞIK E. E., ERTEN S. N., DALAY M. N.

2008 ASCO Annual Meeting, United States Of America, 1 - 04 June 2008, (Full Text)

51. Detection of Histone Methylation On Circulating Nuclesomes In Blood Plasma

GEZER U., YÖRÜKER E. E., Erten S., DALAY M. N.

ASCO Annual Meeting, United States Of America, 1 - 04 June 2008, pp.14590, (Full Text)

52. Kan plazmasında serbest nükleozom ve DNA arasındaki kantitatif ilişkinin incelenmesi.

GEZER U., AKIŞIK E. E., ERTEN S. N., DALAY M. N.

VIII. Ulusal Tıbbi Genetik Kongresi, Çanakkale, Turkey, 1 - 04 May 2008, pp.204, (Full Text)

53. Size Distrubution Circulating Cell-Free DNA In Sera of Breast Cancer Patients In Course of Adjuvant Therapy

GEZER U., Eralp Y., YÖRÜKER E. E., Yılmaz E. Z., SAİP P. M., Topuz E., et al.

Symposium on Circulating Nucleic Acids in Plasma/Serum -V, Russia, 1 - 04 August 2007, pp.9, (Full Text) Sustainable Development

54. Size distribution o circulating cell-free DNA in sera of breast cancer aptients in course of adjuvant therapy

GEZER U., ERALP Y., AKIŞIK E. E., Akışık E. Z., SAİP P. M., Topuz E., et al.

Symposium on Circulating Nucleic Acids in Plasma Serum-V, Russia, 1 - 04 August 2007, pp.9, (Full Text) Sustainable Development

55. Von Hippel Lİndau Ailesinin Genetik Açıdan İncelenmesi

IŞIN M., Beşer A. R., BAŞARAN M., DALAY M. N.

XVII. Ulusal Kanser Kongresi, Antalya, Antalya, Turkey, 19 - 21 April 2007, pp.23-203, (Full Text)

56. Plazma DNA bütünlüğünün kanserde biyomarker potansiyeli

GEZER U., AKIŞIK E. E., ERTEN S. N., DALAY M. N.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2007, pp.193-194, (Full Text) Sustainable Development

57. Myeloid lösemilerde XRCC1 geni kodon 399 polimorfizminin erime eğrisi analizi ile araştırılması

AKIŞIK E. E., GEZER U., DALAY M. N.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2007, pp.194, (Full Text)

58. Plazma Serbest DNA Bütünlüğünün Kanserde Biyomarker Potansiyeli

GEZER U., YÖRÜKER E. E., Erten N., DALAY M. N.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, pp.193-194, (Full Text) Sustainable Development

59. Promoter Methylation and The gIVS12-6T?C Polymorphism of The hMSH2 Gene in Head and Neck Cancer

DEMOKAN S., SÜOĞLU Y., Ulusan M., DALAY N.

31st FEBS Congress, Turkey, 1 - 04 June 2006, vol.273, no.1, pp.190, (Full Text) Sustainable Development

60. Lösemili hastaların mononükleer hücrelerinde TRAİL reseptör ekspresyonu

GEZER U., DALAY M. N.

VII. Prenatal Tanı ve Tıbbi Genetik Kongresi, Kayseri, Turkey, 1 - 04 April 2006, pp.105, (Full Text)

61. Methylation of p16INK4A gene in plasma of patients with multiple myeloma

GEZER U., AKIŞIK E. E., DALAY M. N.

Symposium on Circulating Nucleic Acids in Plasm/Serum-IV, United Kingdom, 1 - 04 September 2005, pp.12, (Full Text)

62. Detection of circulating breast cancer cells in relation to therapy.

Bitisik O., SAİP P. M., Saglam S., Dalay N.

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23, (Summary Text)

63. Hodgkin ve lenfoma ve B hücreli neoplazilerde MTHFR C677T gen polimorfizm dağılımının belirlenmesi

AKIŞIK E. E., GEZER U., AĞAOĞLU F., ERTEN S. N., DALAY M. N.

XVI. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2005, pp.194, (Full Text) Sustainable Development

64. Lenfoma ve myelomalı hastaların periferik dolaşımlarında nükleozomal DNA fragmentasyonu ile kaspaz-3 ilişkisi

GEZER U., AKIŞIK E. E., AĞAOĞLU F., ERTEN S. N., DALAY M. N.

XVI. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2005, pp.197-188, (Summary Text)

65. Clinical features and prognosis of Turkish epithelial ovarian cancer patients with BRCA1 and BRCA2 mutations.

Saip P., Yazici H., Karagol H., Bengisu E., Topuz E., Dalay N.

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 5 - 08 June 2004, vol.22, (Summary Text) Sustainable Development

66. Türk meme kanserli hastalarda XRCC1 gen polimorfizmi ve kanser riski ile ilişkisi

GEZER U., AKIŞIK E. E., DALAY M. N.

8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Turkey, 1 - 04 September 2003, pp.122, (Full Text) Sustainable Development

67. Akut ve Kronik Miyeloid Lösemili Hastalarda p53 Kodon 72 Polimorfizmlerinin Araştırılması

IŞIN M., DALAY M. N.

XV. Ulusal Kanser Kongresi, Antalya, Turkey, 23 - 27 April 2003, pp.188, (Full Text)

68. Lenfoma hastalarının plazmalarında metilenmiş DNA ve nükleozomal DNA

GEZER U., AĞAOĞLU F., ERTEN S. N., DALAY M. N.

XV. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2003, pp.186, (Full Text)

69. Metilentetrahidrofolat redüktaz (MTHFR) gen polimorfizmi ve meme kanseri riski

GEZER U., YAZICI ÖZBEK H., YASASEVER F. V., DALAY M. N.

XV. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2003, pp.186-187, (Full Text) Sustainable Development

70. HER2, estrogen receptor and methylenetetrahydrofolate gene polymorphisms in breast cancer.

Dalay N., Akisik E., Deligezer U.

26th Annual San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 3 - 06 December 2003, vol.82, (Summary Text) Sustainable Development